PATENT CLAIM ANALYSIS

Application Number: 16426905
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-10
Patent Classification: ["435", "325000"]

Abstract:
Compositions comprising synthetic membrane-receiver complexes, methods of generating synthetic membrane-receiver complexes, and methods of treating or preventing diseases, disorders or conditions therewith.

Claim (Index 19):
The enucleated erythroid cell of  claim 1 , wherein the nucleated erythroid cell precursor is a CD34+ hematopoietic stem cell.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 100.0
- Lexical Diversity: 1.44444
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16409576', '15925212', '16195811', '15783921', '15824877']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7089548862209543
- 35 USC 102 Novelty (BERT): 0.6579785505989436
- Combined Prediction Score: 0.7038572526587532
- Mean Citation Score: 616.8888920000003
- Max Citation Score: 628.19305
- Similarity Product: 625.56726905891

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test